Europe PCR Technologies Market Forecast to 2030

Europe PCR Technologies Market Forecast to 2030

Europe PCR Technologies Market Forecast to 2030 – Regional Analysis – by Technology (Real-Time PCR, Conventional PCR, Reverse Transcription PCR, Digital PCR, Multiplex RT PCR, Hot Start PCR, and Others), Offerings (Reagents & Consumables, Instruments, and Software & Services), Application (Gene Expression Analysis, Genetic Sequencing, Genotyping, Nucleic Acid Synthesis, Standard Validation, Point of Care Diagnostics, Environmental Application, and Others), and End User (Hospitals & Diagnostic Centers, Academia & Research Institutes, Pharmaceutical and Biotechnology Companies, and Others)

Send Enquiry
Item ID: BMIRE00030425 Category: Tag:

$2,485 – $3,885

Description

The Europe PCR technologies market is expected to grow from US$ 3,880.13 million in 2022 to US$ 7,173.73 million by 2030. It is estimated to record a CAGR of 8.0% from 2022 to 2030.

Increasing Adoption of PCR Techniques in Emerging Countries Drives Europe PCR Technologies Market

Point-of-care (POC) testing presents a significant opportunity for the PCR technology market by expanding its reach and applications. PCR technology, known for its accuracy and sensitivity, is increasingly being adapted for POC testing due to its ability to deliver rapid and reliable results at or near the point of care. As POC testing becomes more prevalent in healthcare settings such as clinics, emergency departments, and decentralized facilities, the demand for PCR platforms and assays tailored for POC applications is expected to rise.

PCR’s advantages, including the ability to detect infectious diseases with high specificity and sensitivity, make it well-suited for POC testing, particularly in situations requiring rapid diagnosis and treatment decisions. Additionally, the miniaturization and automation of PCR systems further enable their integration into POC settings, facilitating on-site testing and improving patient care outcomes. As healthcare providers increasingly recognize the value of POC PCR testing in enhancing diagnostic capabilities and patient management, the market for POC PCR technologies is poised for growth and innovation.

Europe PCR Technologies Market Overview

The European PCR technologies market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Funds made available by government and private organizations for advanced research, the launch of innovative technologies for artificial DNA synthesis, and an increase in various research studies for novel technology-based applications drive the growth of the PCR technologies market in Europe. In addition, efforts taken by the national governments to encourage innovation through incentive provisions and tax exemptions for R&D and new biotech start-ups are expected to favour the European PCR technologies market growth over the forecast period. Germany is one of the largest biotechnology hubs in Europe and worldwide owing to the presence of prominent biotech players, high-tech research labs, and massive funding for conducting research and development activities in the new areas of science and technology. The country has more biotechnology companies than any other European country. The cutting-edge and high-quality research ongoing in Germany creates lucrative opportunities for the already established market for PCR technologies. Individual researchers and academic universities in the country collaborate with international laboratories and institutions to create breakthrough innovations. The rising funds and grants and increasing use of synthetic biology in various application areas are the major factors favoring the growth of the German PCR technologies market. The German government considers the formation of startups to be an essential part of the development of the biotechnology industry in the country. For instance, BIO Deutschland is a sector association of the German biotech industry based in Berlin, with over 330 members that promote and support the development of the industry to help it bloom as a robust economic entity. Similarly, Euronext is another organization that recognizes and utilizes the current momentum of the biotech industry. It thus assists startups by creating jobs, raising funds and investments, and supporting the companies in various other ways.

Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

Europe PCR Technologies Market Segmentation

The Europe PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the Europe PCR technologies market is categorized into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of Europe PCR technologies market in 2022.

In terms of offerings, the Europe PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Europe PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

By application, the Europe PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Europe PCR technologies market in 2022.

Based on end user, the Europe PCR technologies market is segmented into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of Europe PCR technologies market in 2022.

By country, the Europe PCR technologies market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd are some of the leading companies operating in the Europe PCR technologies market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 8.0% CAGR, Europe PCR Technologies Market is Speculated to be Worth US$ 7,173.73 Million by 2030, says the Research Team

According to the Research Team research, the Europe PCR technologies market was valued at US$ 3,880.13 million in 2022 and is expected to reach US$ 7,173.73 million by 2030, registering a CAGR of 8.0% from 2022 to 2030. Rising prevalence of genetic and infectious diseases and surging investments and funds availability for PCR technologies are among the critical factors attributed to the Europe PCR technologies market expansion.

Government and federal agencies worldwide recognize the role of quantitative polymerase chain reaction (qPCR) and dPCR products in genome-based research. In 2021, the multiplex digital PCR startup Stilla Technologies raised US$ 34 million (31.3 million) through the issuance of US$ 12.25 million (11.3 million) in convertible bonds and US$ 21.7 million (20 million) in loan funding. Apart from new funding provided by current backers Illumina Ventures, Kurma Partners, TusPark Capital Management, LBO France, BNP Paribas Developpement, and Eurazeo, Stilla has also drawn investments from the European Investment Bank (EIB) and eminent life science company Casdin Capital. Some companies have also increased their research and development funds for the enhancement of gene synthesis. In 2021, Camena Bioscience, a synthetic biology startup that supplies genes to the biotechnology and pharmaceutical sectors, completed a US$ 10 million Series A funding round headed by Mercia. With the additional funds, the company expanded its operations and continued the development of its ground-breaking DNA synthesis platform-gSynth. The technology platform and other related resources help the company accelerate the development of gene synthesis. Therefore, the increasing availability of financial support for research and development in disease-specific genomics propels the demand for PCR technologies.

On the contrary, high costs of PCR systems and availability of alternative assay hampers the growth of Europe PCR technologies market.

Based on technology, the Europe PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held 38.9% share of Europe PCR technologies market in 2022, amassing US$ 1,510.58 million. It is projected to garner US$ 2,940.40 million by 2030 to expand at 8.7% CAGR during 2022-2030.

In terms of offerings, the Europe PCR technologies market is categorized into reagents & consumables, instruments, and software & services. The reagents & consumables segment held 59.9% share of Europe PCR technologies market in 2022, amassing US$ 2,322.29 million. It is projected to garner US$ 4,589.28 million by 2030 to expand at 8.9% CAGR during 2022-2030. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

By application, the Europe PCR technologies market is segmented gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held 23.6% share of Europe PCR technologies market in 2022, amassing US$ 915.48 million. It is projected to garner US$ 1,806.09 million by 2030 to expand at 8.9% CAGR during 2022-2030.

Based on end user, the Europe PCR technologies market is segmented hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centers segment held 57.1% share of Europe PCR technologies market in 2022, amassing US$ 2,216.54 million. It is projected to garner US$ 4,256.96 million by 2030 to expand at 8.5% CAGR during 2022-2030.

By country, the Europe PCR technologies market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 26.5% share of Europe PCR technologies market in 2022. It was assessed at US$ 1,028.55 million in 2022 and is likely to hit US$ 1,926.95 million by 2030, exhibiting a CAGR of 8.2% during 2022-2030.

Key players operating in the Europe PCR technologies market are Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd, among others.

In February 2021, Thermo Fisher Scientific Inc announced the complete acquisition of Mesa Biotech Inc, a point-of-care molecular diagnostic company. The acquisition has allowed Thermo Fisher Scientific Inc to expand its portfolio with a point-of-care PCR-based testing platform for infectious disease diagnosis. And since 2021, Mesa Biotech Inc has become a part of the Life Sciences Solution Segment.

In April 2022, Stilla Technologies and Promega Corporation announced a co-marketing agreement that combines sample preparation with the latest Maxwell systems and digital PCR on the six-color naica system. With this partnership, the companies will offer an optimized workflow for various applications, including liquid biopsy, sentinel pathogen testing, infectious disease assays, cancer research, and drug discovery.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe PCR technologies market.
o Highlights key business priorities to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe PCR technologies market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe PCR Technologies Market – Key Industry Dynamics
4.1 PCR Technologies Market – Key Industry Dynamics
4.2 Market Drivers
4.2.1 Rising Prevalence of Genetic and Infectious Diseases
4.2.2 Surging Investments and Funds Availability for PCR Technologies
4.3 Market Restraints
4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
4.4 Market Opportunities
4.4.1 Increasing Demand for POC Testing
4.5 Future Trends
4.5.1 Advancements in PCR Technologies
4.6 Impact of Drivers and Restraints:
5. PCR Technologies Market – Europe Market Analysis
5.1 PCR Technologies Market Revenue (US$ Million), 2020 – 2030
6. Europe PCR Technologies Market Analysis – By Technology
6.1 Overview
6.2 Real Time PCR
6.2.1 Overview
6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Conventional PCR
6.3.1 Overview
6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Reverse Transcription PCR
6.4.1 Overview
6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Digital PCR
6.5.1 Overview
6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.6 Multiplex RT PCR
6.6.1 Overview
6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.7 Hot Start PCR
6.7.1 Overview
6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
7. Europe PCR Technologies Market Analysis – By Offerings
7.1 Overview
7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Reagents and Consumables
7.3.2.1.1 PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Vial Size
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Instruments
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)
8. Europe PCR Technologies Market Analysis – By Application
8.1 Overview
8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Gene Expression Analysis
8.3.1 Overview
8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Genetic Sequencing
8.4.1 Overview
8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
8.5 Genotyping
8.5.1 Overview
8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
8.6 Nucleic Acid Synthesis
8.6.1 Overview
8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
8.7 Standard Validation
8.7.1 Overview
8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
8.8 Point of Care Diagnostics
8.8.1 Overview
8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
8.9 Environmental Application
8.9.1 Overview
8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. Europe PCR Technologies Market Analysis – By End User
9.1 Overview
9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Academia and Research Institutes
9.4.1 Overview
9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Pharmaceutical and Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
10. Europe PCR Technologies Market -Country Analysis
10.1 Europe: PCR Technologies Market
10.1.1 Overview
10.1.2 Europe PCR Technologies Market Revenue and Forecast and Analysis – By Country
10.1.2.1 Germany
10.1.2.1.1 Overview
10.1.2.2 Germany PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.1 Germany PCR Technologies Market Breakdown by Technology
10.1.2.2.2 Germany PCR Technologies Market Breakdown by Offerings
10.1.2.2.2.1 Germany PCR Technologies Market Breakdown by Instruments
10.1.2.2.2.2 Germany PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.2.2.2.1 Germany PCR Technologies Market Breakdown by Vial Size
10.1.2.2.3 Germany PCR Technologies Market Breakdown by Application
10.1.2.2.4 Germany PCR Technologies Market Breakdown by End User
10.1.2.3 United Kingdom
10.1.2.3.1 Overview
10.1.2.4 United Kingdom PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.1 United Kingdom PCR Technologies Market Breakdown by Technology
10.1.2.4.2 United Kingdom PCR Technologies Market Breakdown by Offerings
10.1.2.4.2.1 United Kingdom PCR Technologies Market Breakdown by Instruments
10.1.2.4.2.2 United Kingdom PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.4.2.2.1 United Kingdom PCR Technologies Market Breakdown by Vial Size
10.1.2.4.3 United Kingdom PCR Technologies Market Breakdown by Application
10.1.2.4.4 United Kingdom PCR Technologies Market Breakdown by End User
10.1.2.5 France
10.1.2.5.1 Overview
10.1.2.6 France PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.1 France PCR Technologies Market Breakdown by Offerings
10.1.2.6.1.1 France PCR Technologies Market Breakdown by Instruments
10.1.2.6.1.2 France PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.6.1.2.1 France PCR Technologies Market Breakdown by Vial Size
10.1.2.6.2 France PCR Technologies Market Breakdown by Application
10.1.2.6.3 France PCR Technologies Market Breakdown by End User
10.1.2.7 Italy
10.1.2.7.1 Overview
10.1.2.8 Italy PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.8.1 Italy PCR Technologies Market Breakdown by Technology
10.1.2.8.2 Italy PCR Technologies Market Breakdown by Offerings
10.1.2.8.2.1 Italy PCR Technologies Market Breakdown by Instruments
10.1.2.8.2.2 Italy PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.8.2.2.1 Italy PCR Technologies Market Breakdown by Vial Size
10.1.2.8.3 Italy PCR Technologies Market Breakdown by Application
10.1.2.8.4 Italy PCR Technologies Market Breakdown by End User
10.1.2.9 Spain
10.1.2.9.1 Overview
10.1.2.10 Spain PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.10.1 Spain PCR Technologies Market Breakdown by Technology
10.1.2.10.2 Spain PCR Technologies Market Breakdown by Offerings
10.1.2.10.2.1 Spain PCR Technologies Market Breakdown by Instruments
10.1.2.10.2.2 Spain PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.10.2.2.1 Spain PCR Technologies Market Breakdown by Vial Size
10.1.2.10.3 Spain PCR Technologies Market Breakdown by Application
10.1.2.10.4 Spain PCR Technologies Market Breakdown by End User
10.1.2.11 Rest of Europe
10.1.2.11.1 Overview
10.1.2.12 Rest of Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.12.1 Rest of Europe PCR Technologies Market Breakdown by Technology
10.1.2.12.2 Rest of Europe PCR Technologies Market Breakdown by Offerings
10.1.2.12.2.1 Rest of Europe PCR Technologies Market Breakdown by Instruments
10.1.2.12.2.2 Rest of Europe PCR Technologies Market Breakdown by Reagents and Consumables
10.1.2.12.2.2.1 Rest of Europe PCR Technologies Market Breakdown by Vial Size
10.1.2.12.3 Rest of Europe PCR Technologies Market Breakdown by Application
10.1.2.12.4 Rest of Europe PCR Technologies Market Breakdown by End User
11. PCR Technologies Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the PCR Technologies Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN NV
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 bioMerieux SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hoffmann-La Roche Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bio-Rad Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Becton Dickinson and Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Takara Bio Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Standard Biotools Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Agilent Technologies Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Ellume Ltd
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About the the Reporting Teams
13.2 Glossary of Terms

LIST OF TABLES

Table 1. PCR Technologies Market Segmentation
Table 2. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Technology
Table 3. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Offerings
Table 4. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Reagents and Consumables
Table 5. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Vial Size
Table 6. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Instruments
Table 7. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By Application
Table 8. PCR Technologies Market – Revenue and Forecast to 2030(US$ Million) – By End User
Table 9. Germany PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 10. Germany PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 11. Germany PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 12. Germany PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 13. Germany PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 14. Germany PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 15. Germany PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 16. United Kingdom PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 17. United Kingdom PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 18. United Kingdom PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 19. United Kingdom PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 20. United Kingdom PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 21. United Kingdom PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 22. United Kingdom PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 23. France PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 24. France PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 25. France PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 26. France PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 27. France PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 28. France PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 29. France PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 30. Italy PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 31. Italy PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 32. Italy PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 33. Italy PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 34. Italy PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 35. Italy PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 36. Italy PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 37. Spain PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 38. Spain PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 39. Spain PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 40. Spain PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 41. Spain PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 42. Spain PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 43. Spain PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 44. Rest of Europe PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Technology
Table 45. Rest of Europe PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Offerings
Table 46. Rest of Europe PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Instruments
Table 47. Rest of Europe PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Reagents and Consumables
Table 48. Rest of Europe PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Vial Size
Table 49. Rest of Europe PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By Application
Table 50. Rest of Europe PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn) – By End User
Table 51. Recent Inorganic Growth Strategies in the PCR Technologies Market
Table 52. Recent Organic Growth Strategies in the PCR Technologies Market
Table 53. Glossary of Terms, PCR Technologies Market

LIST OF FIGURES

Figure 1. PCR Technologies Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 – 2030
Figure 4. PCR Technologies Market Share (%) – By Technology, 2022 and 2030
Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. PCR Technologies Market Share (%) – By Offerings, 2022 and 2030
Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. PCR Technologies Market Share (%) – By Application, 2022 and 2030
Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 25. PCR Technologies Market Share (%) – By End User, 2022 and 2030
Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 30. Europe: PCR Technologies Market, by Key Country – Revenue (2022) (US$ Million)
Figure 31. Europe PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 32. Germany PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 33. United Kingdom PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 34. France PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 35. Italy PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 36. Spain PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 37. Rest of Europe PCR Technologies Market – Revenue and Forecast to 2030(US$ Mn)
Figure 38. Growth Strategies in the PCR Technologies Market

The List of Companies – Europe PCR Technologies Market

1. Thermo Fisher Scientific Inc
2. Promega Corp
3. QIAGEN NV
4. bioMerieux SA
5. Hoffmann-La Roche Ltd
6. Bio-Rad Laboratories Inc
7. Becton Dickinson and Co
8. Takara Bio Inc
9. Standard BioTools Inc
10. Agilent Technologies Inc
11. Ellume Ltd

Reviews

There are no reviews yet.

Be the first to review “Europe PCR Technologies Market Forecast to 2030”